Loading...
Naman Global Impex Private Limited — Combiflam Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Combiflam · $1.6K export value · DGFT Verified
Naman Global Impex Private Limited is the #4 Indian exporter of Combiflam with $1.6K in export value and 5 verified shipments. Naman Global Impex Private Limited holds a 6.6% market share in Combiflam exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| SEYCHELLES | $12.9K | 99 | 53.4% |
| GUINEA | $4.2K | 2 | 17.3% |
| AFGHANISTAN | $3.3K | 6 | 13.4% |
| CAYMAN ISLANDS | $1.2K | 22 | 4.8% |
| PAKISTAN | $1.1K | 4 | 4.4% |
| TAJIKISTAN | $519 | 5 | 2.1% |
| DOMINICA | $396 | 7 | 1.6% |
| UNITED KINGDOM | $215 | 3 | 0.9% |
| UNITED STATES | $131 | 3 | 0.5% |
| SOUTH AFRICA | $110 | 1 | 0.5% |
India exports Combiflam to 21 countries. The top destination is SEYCHELLES (53.4%), followed by GUINEA and AFGHANISTAN.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ODHAV MULTI INDUSTRIES SA | GUINEA | $4.2K | 2 |
| VMK MEDICAL ENTERPRISES | SEYCHELLES | $4.1K | 3 |
| HAROON TIMOR ZAHIRI LIMITED | AFGHANISTAN | $2.0K | 3 |
India's Combiflam is purchased by 68 buyers worldwide. The top buyer is ODHAV MULTI INDUSTRIES SA (GUINEA), followed by VMK MEDICAL ENTERPRISES and HAROON TIMOR ZAHIRI LIMITED.
India exported $12.9K worth of Combiflam through 174 shipments from 42 suppliers to 21 countries, serving 68 buyers globally. Naman Global Impex Private Limited contributes $1.6K to this total, accounting for 6.6% of India's Combiflam exports.
Naman Global Impex Private Limited's average Combiflam shipment value is $321 per consignment, based on 5 shipments totaling $1.6K.
Naman Global Impex Private Limited ranks #4 among 42 Indian Combiflam exporters with a 6.6% market share. The top 3 exporters are CAPSTONE EXPORT & IMPORT ($5.1K), VEA IMPEX (I) PRIVATE LIMITED ($2.2K), SHAURYA INTERNATIONAL ($2.0K). Naman Global Impex Private Limited processed 5 shipments to 1 destination countries.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | VEA IMPEX (I) PRIVATE LIMITED | $2.2K | 30 | 4 | $73 |
| 3 | SHAURYA INTERNATIONAL | $2.0K | 3 | 1 | $666 |
| 4 | NAMAN GLOBAL IMPEX PRIVATE LIMITED ★ | $1.6K | 5 | 1 | $321 |
| 5 | N CHIMANLAL ENTERPRISES | $1.0K | 9 | 2 | $115 |
| 6 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 31 | 17.8% |
| CHENNAI AIR | 25 | 14.4% |
| SAHAR AIR | 23 | 13.2% |
| CHENNAI AIR CARGO ACC (INMAA4) | 16 | 9.2% |
| Bombay Air | 15 | 8.6% |
| TUGLAKABAD ICD (INTKD6) | 7 | 4.0% |
| BANGALORE AIR | 6 | 3.4% |
| Bombay Air Cargo | 6 | 3.4% |
Latest developments and market context
Detailed market intelligence for Combiflam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Naman Global Impex Private Limited's Combiflam exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| JINDAL MEDICAL STORE |
| $1.0K |
| 3 |
| 2 |
| $337 |
Naman Global Impex Private Limited ranks #4 among 42 Indian Combiflam exporters. Average shipment value of $321 compared to the market average of $308. The closest competitors by value are VEA IMPEX (I) PRIVATE LIMITED and SHAURYA INTERNATIONAL.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 21+ countries, 68+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Naman Global Impex Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Combiflam. For current shipment-level data, contact TransData Nexus.